Abstract. To 
Intravenous administration of GHRH(1\p=n-\44)NH2 (100 \g=m\g) elicited a marked plasma GH response with a maximum peak (709.54 \ m=+-\259.0 (Rossor et al. 1984 (Coyle et al. 1983 ), but at present it is believed that this patho¬ logical process is a multisystem disorder (Price et al. 1986 ). The most relevant peptidergic abnor¬ malities in SDAT involve a clear deficit in cortical somatostatin (Davies et al. 1980; Rossor et al. 1984; Beai et al. 1986 ) and CRH (Bissette et al. 1985; De Souza et al. 1986 ). Other peptidergic and monoaminergic systems are also affected (see Beai et al. 1986; Cacabelos et al. 1986a Cacabelos et al. , 1987b SDAT. This is in part due to the fact that most authors agree that the GH response to GHRH is attenuated in elderly subjects (Guillemin et al. 1984; Shibasaki et al. 1984) and old laboratory animals (Sonntag et The rationale for giving GHRH to these pa¬ tients is indicated by the fact that this neuropep¬ tide has proved to be effective in enhancing food intake (Vaccarino et al. 1985) , locomotion, and, to a lesser extent, learning in a dose-dependent manner in rats (Cacabelos et al. 1987a,c) . Since these behavioural parameters are impaired in SDAT, it would be worthwhile to investigate whether GHRH may be of utility as a palliative treatment (Cacabelos et al. 1986a (Cacabelos et al. , 1987a . The second matter to take into consideration is the necessity of establishing accurate antemortem markers for SDAT (Hollander et al. 1986 ). In this regard, the determination of basal levels of corti¬ sol ) and GH (Christie et al. 1986) appears to be a useful diagnostic tool. Another approach to the problem should be to use neuro¬ endocrine tests (Cacabelos et al. 1987b) 15, 30, 45, 60, 90 , and 120 min after injection for determi¬ nation of GH concentrations in plasma. Blood samples were treated as previously described (Cacabelos et al. 1985) and the plasma GH levels were measured by RIA using a commercial GH-RIA-Kit (Dainabot Co Ltd, Tokyo). The intra-and inter-assay coefficients of varia¬ tion were 6.9% and 10.6%, respectively.
Simultaneously to the performance of the GHRH (Davies et al. 1980; Rossor et al. 1984 ; Our EEG records agree with most data cur¬ rently reported (Mclntyre 1985; Fenton 1986 ). (Cacabelos et al. 1986a (Cacabelos et al. , 1987a 
